The largest integrin subfamily is composed by integrin β1 (CD29) that is able to associates with 12 different α subunits (α1-11 and αv). Integrin β1 together with integrin chains α4, α5, α6 and α9 are expressed by murine hematopoietic stem and progenitor cells (HSPCs) and play important roles in regulating their BM retention, migration and development.
sequence homology with other integrin α subunits, the α4 strand because of the lack of the inserted Idomain doesn't undergo post-translational cleavage near the transmembrane region. Finally, the α4 chain contains a trypsin-like cleavage site, constitutively expressed on most leukocytes and on hematopoietic stem and progenitor cells (Hynes, 1992) .
VLA-4 plays a major role in the regulation of immune cell recruitment to inflamed endothelia and sites of inflammation through its interactions with two alternative ligands, vascular cell adhesion molecule-1 (VCAM-1) and the alternatively spliced connecting segment 1 (CS-1) of fibronectin (Hemler, 1990; Papayannopoulou et al., 1998) . It also participates in many cellular events and is crucial for BM retention and mobilization of immature stem and progenitors cells from the bone marrow (Lapidot and Petit, 2002; Peled et al., 2000) .
Migration of hematopoietic stem cells to the bone marrow is a regulated multistep process that requires precise regulation and activation of various molecules including chemoattractants, selectins and integrins. While the initial steps of hematopoietic stem and progenitor cells tethering and rolling along BM blood vessel endothelium are primarily regulated by selectins, various integrins have been shown to be involved in the next stages of this process. VLA-4 plays an important role in homing, lodgment and retention of HSCs within the marrow microenvironment (Rettig et al., 2012 ). Previous studies demonstrate that treatment of donor BM cells with a neutralizing anti α4 integrin antibody before injection into lethally irradiated recipients, inhibits their homing to the femurs of recipient mice, increasing the number of HSPCs in the peripheral blood and spleen. Moreover, recipient mice pretreated with neutralizing antibodies against VCAM-1 gave similar results, adding evidences to the important role of the VLA-4/VCAM-1 axis in HSPC homing to the bone marrow (Papayannopoulou et al., 1995) . 1. Sacrifice desired mice strain by CO2 euthanization or cervical dislocation.
2. Extract the femurs, tibias and iliac crest bones using forceps and sharp scissors. Place the bones in a small dish supplemented with PBS +/+ on ice.
3. Flush total bone marrow cells from the bone cavity with 1-5 ml ice cold PBS (per mouse) using a 1 ml syringe and 25 G needle. Obtain single cell suspension by simply resuspending the cell solution using the same syringe. 
